Clinical presentation of immune checkpoint inhibitor-induced inflammatory arthritis differs by immunotherapy regimen

This study aimed to characterize clinical phenotypes, IA treatment and response in the largest cohort of patients with ICI-induced IA reported to date.

Source: Seminars in Arthritis and Rheumatism - February 22, 2018 Category: Rheumatology Authors: Laura C. Cappelli, Julie R. Brahmer, Patrick M. Forde, Dung T. Le, Evan J. Lipson, Jarushka Naidoo, Lei Zheng, Clifton O. Bingham, Ami A. Shah Source Type: research